Patent · US Active

Highly purifid pharmaceutical grade tasimelteon

US10071977B2 · kind B2 · utility

13Cited by
2References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 12, 2015
Grant dateSep 11, 2018
Priority date
Expiry dateFeb 12, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D307/79
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A process for preparing a batch of highly purified, pharmaceutical grade tasimelteon comprises analyzing a batch of tasimelteon synthesized under GMP conditions for the presence of one or more identified impurities.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.